Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping review.
Monika Pury OktoraK P KerrEelko HakPetra DenigPublished in: Diabetic medicine : a journal of the British Diabetic Association (2020)
Deprescribing of glucose-lowering medications seems feasible and acceptable, but was not widely implemented in the covered period. Support systems may enhance deprescribing. More studies on deprescribing blood pressure- and lipid-lowering medications in people with diabetes are needed.